retatrutide news is an experimental weight-loss drug not approved by the FDA – and yet, you can buy it in a New York City bodega., CBS has been investigating the black market for retatrutide, which TRIUMPH-1 Trial Shows Potential for
Description
Or at least, it is incomplete in ways that matter enormously for what you do next

The effects of GLP-1s increase postprandial insulin secretion from pancreatic -cells, suppress glucagon secretion from -cells, slow gastric emptying, and reduce appetite (Gross)
The worst rare side effects are pancreatitis (0.3%), gallbladder problems (1.4%), and acute kidney injury (0.7%), all occurring in under 2% of patients

The SELECT trial (Lincoff et al

doi: 10.1038/s41569-023-00849-3